Crossmark

Daily versus every other day oral iron supplementation in patients with iron deficiency anemia (DEODO): study protocol for a phase 3 multicentered, pragmatic, open-label, pilot randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s40814-022-01042-y

Published Online: 2022-05-04

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kron, Amie

Del Giudice, M. Elisabeth

Sholzberg, Michelle

Callum, Jeannie

Cserti-Gazdewich, Christine

Swarup, Vidushi

Huang, Mary

Distefano, Lanis

Anani, Waseem

Skeate, Robert

Armali, Chantal

Lin, Yulia https://orcid.org/0000-0002-5562-9020
Funding

Funding for this research was provided by:

Canadian Blood Services Transfusion Medicine Research Program Support Award

University of Toronto, Alexandra Yeo Chair Grant in Benign Hematology
License Information

Text and Data Mining valid from 2022-05-04

Version of Record valid from 2022-05-04
More Information

Article History

Received: 16 January 2021

Accepted: 4 April 2022

First Online: 4 May 2022

Declarations

:

: Health Canada (file no. 240558), Sunnybrook Research Ethics Board (Additional file 4), and St. Michael’s Hospital Research Ethics Board (Additional file 5) reviewed and approved the protocol, site-specific informed consent forms, participant recruitment materials, and study supporting documents. Written, informed consent to participate is obtained from all participants.

: Not applicable

: Jeannie Callum has research support from Canadian Blood Services, Canadian Institutes for Health Research, and Octapharma Canada. Yulia Lin has received research funding from Novartis and consulting fees from Pfizer.

Document is current

Any future updates will be listed below